alex.hogeland@engagehealthmedia.com

Choosing the Route of Administration for Disease-Modifying Therapies
Neurology

Choosing the Route of Administration for Disease-Modifying Therapies

Landscape Article
By Christopher Ontiveros, PhD
The Variable Clinical Progression of Spinal Muscular Atrophy
Neurology

The Variable Clinical Progression of Spinal Muscular Atrophy

expert roundtables
By John Brandsema, MD; Jenna Klotz, MD, MS; Julie A. Parsons, MD
The Biology and Clinical Course of Advanced ROS1-Positive Non–Small Cell Lung Cancer
Oncology

The Biology and Clinical Course of Advanced ROS1-Positive Non–Small Cell Lung Cancer

clinical topic updates
By D. Ross Camidge, MD, PhD
Choosing Treatment for Brain Metastases in ROS1-Altered Non–Small Cell Lung Cancer
Oncology

Choosing Treatment for Brain Metastases in ROS1-Altered Non–Small Cell Lung Cancer

patient care perspectives
By D. Ross Camidge, MD, PhD
New Drug Development and Treatment Considerations for Spinal Muscular Atrophy
Neurology

New Drug Development and Treatment Considerations for Spinal Muscular Atrophy

expert roundtables
By John Brandsema, MD; Jenna Klotz, MD, MS; Julie A. Parsons, MD
Load More